These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24872311)

  • 41. Nonalcoholic fatty liver disease and polycystic ovary syndrome.
    Vassilatou E
    World J Gastroenterol; 2014 Jul; 20(26):8351-63. PubMed ID: 25024594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin resistance, polycystic ovary syndrome and metformin.
    Pugeat M; Ducluzeau PH
    Drugs; 1999; 58 Suppl 1():41-6; discussion 75-82. PubMed ID: 10576524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mean and the biological variation of insulin resistance does not differ between polycystic ovary syndrome and type 2 diabetes.
    Cho LW; Jayagopal V; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2009 May; 46(Pt 3):218-21. PubMed ID: 19389885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insulin resistance and polycystic ovary syndrome through life.
    Diamanti-Kandarakis E; Spritzer PM; Sir-Petermann T; Motta AB
    Curr Pharm Des; 2012; 18(34):5569-76. PubMed ID: 22834924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Polycystic ovary syndrome and insulin resistance].
    Puder J; Pralong F
    Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
    González F
    Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polycystic ovary syndrome in adolescence.
    Buggs C; Rosenfield RL
    Endocrinol Metab Clin North Am; 2005 Sep; 34(3):677-705, x. PubMed ID: 16085166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current concepts in the polycystic ovary syndrome.
    Dunaif A; Thomas A
    Annu Rev Med; 2001; 52():401-19. PubMed ID: 11160786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
    Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
    J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin action in the polycystic ovary syndrome.
    Dunaif A
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):341-59. PubMed ID: 10352922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.
    Diamanti-Kandarakis E; Dunaif A
    Endocr Rev; 2012 Dec; 33(6):981-1030. PubMed ID: 23065822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E
    Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic syndrome and polycystic ovary syndrome: an intriguing overlapping.
    Caserta D; Adducchio G; Picchia S; Ralli E; Matteucci E; Moscarini M
    Gynecol Endocrinol; 2014 Jun; 30(6):397-402. PubMed ID: 24552422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypothetical physiological and molecular basis for the effect of acupuncture in the treatment of polycystic ovary syndrome.
    Stener-Victorin E
    Mol Cell Endocrinol; 2013 Jul; 373(1-2):83-90. PubMed ID: 23416841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
    Giallauria F; Palomba S; Maresca L; Vuolo L; Tafuri D; Lombardi G; Colao A; Vigorito C; Francesco O
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):792-8. PubMed ID: 18505468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.